Corvus Pharmaceuticals Common Stock Payments (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

18.37 +0.55 (+3.09%) USD | NASDAQ | Feb 25, 14:40

View Common Stock Payments (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Common Stock Payments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Common Stock Payments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Common Stock Payments (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Plus Therapeutics, Inc.	Upgrade
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--